Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; A Prospective Non Randomised Open Label Multicenter Phase Two Study in Male Longterm Survivors of Malignant Lymphoma (Vitality)
Latest Information Update: 15 Sep 2023
At a glance
- Drugs Testosterone (Primary) ; Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- Acronyms Vitality
Most Recent Events
- 28 Nov 2022 Status changed from active, no longer recruiting to completed.
- 17 Mar 2022 Planned End Date changed from 1 Nov 2022 to 28 Feb 2023.
- 17 Mar 2022 Planned primary completion date changed from 1 Nov 2022 to 31 Jan 2023.